GSE62843,GSE64371 4 V 0 FURAN MOUSE DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE62843,GSE64371 4 V 0 FURAN MOUSE DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE62843,GSE64371 4 V 0 FURAN MOUSE DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE62843,GSE64371 4 V 0 FURAN MOUSE DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE62843,GSE64371 4 V 0 FURAN MOUSE DN.

Results found

Linked to

 

Label

Description

 

Gene

POU class 3 homeobox 3

Gene

leukocyte receptor cluster member 9

Gene

ciliary microtubule inner protein 3

Gene

estrogen receptor binding site associated antigen 9

Gene

SFT2 domain containing 2

Gene

tetratricopeptide repeat domain 9B

Gene

euchromatic histone lysine methyltransferase 1

Gene

kelch domain containing 7A

Gene

holocarboxylase synthetase

Gene

POU class 1 homeobox 1

  • Gene

    POU class 3 homeobox 3


  • Gene

    leukocyte receptor cluster member 9


  • Gene

    ciliary microtubule inner protein 3


  • Gene

    estrogen receptor binding site associated antigen 9


  • Gene

    SFT2 domain containing 2


  • Gene

    tetratricopeptide repeat domain 9B


  • Gene

    euchromatic histone lysine methyltransferase 1


  • Gene

    kelch domain containing 7A


  • Gene

    holocarboxylase synthetase


  • Gene

    POU class 1 homeobox 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.